Tackling the second biggest killer of mothers Harshad Sanghvi Vice President & Medical Director, Jhpiego Monday 10 March, 2010, Bangkok, Thailand.

Slides:



Advertisements
Similar presentations
PPH Prevention through platform of antenatal care Albert Kitumbo, MD Ifakara Health Institute.
Advertisements

Preventing PPH: Community Based Distribution of Misoprostol Harshad Sanghvi Vice President & Medical Director, Jhpiego.
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Maternal and Newborn Indicator Validation Study in Mozambique A collaboration between Maternal Child Health Integrated Program (MCHIP), Child Health Epidemiology.
REDUCING MATERNAL AND NEONATAL MORTALITY IN MOZAMBIQUE THE CHALLENGE IN THE NEW MILLENIUM.
Maternal Survival in Afghanistan: Progress and Challenges Mary Ellen Stanton Senior Maternal Health Advisor Bureau for Global Health, USAID Health in Afghanistan:
EFFORTS TO PREVENT MATERNAL AND NEWBORN MORBIDITY AND MORTALITY IN KISARAWE DR. M.O. KISANGA KISARAWE INTRODUCTION Kisarawe District is among the seven.
HYPERTENSIVE DISEASE IN PREGNANCY WITH ASSOCIATED NEONATAL OUTCOMES
More proven interventions are available to prevent and treat diarrhea than any other major child killer Jones G Bryce J. et al. Lancet UNICEF. Diarrhoea:
Building Community Orientated Primary Care in Mali Group One.
Neonatal Mortality in Ghana Keeps MDG 4 at the Crossroads.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Improved Labor Care to Reduce Neonatal Asphyxia Jeffrey M. Smith Maternal Health Team Leader Interventions for Impact in Essential Obstetric and Newborn.
Strengthening Health Facilities for Maternal Newborn Care: experiences from rural eastern Uganda Authors: G Namazzi, P. Waiswa, S. Peterson R. Byaruhanga,
We can prevent mortality from eclampsia Harshad Sanghvi Vice President & Medical Director, Jhpiego Monday 8 March, 2010, Bangkok, Thailand.
The Role of Midwives in MCH 17 th of February, 2009 Alison Lindner BSN, CNM, MPH.
Magnesium sulphate in the Management of Eclampsia in Malawi Dr. Chisale Mhango FRCOG 1 NPC Training in MNH.
Factors Affecting Maternal Mortality (MM) in Turkey and in the World Dr. Yeşim YASİN Spring-2014.
Maternal Mortality & the MDGs Deborah Maine Professor, International Health Boston University, School of Public Health.
How to IMPLEMENT responses. Who and when ? IMMEDIATEPERIODICLONG TERM Region National Woreda Facility Comm’ty Level and timing of action.
Ms. Mariyam Nazviya Ministry of Health & Family Republic of Maldives ESA/STAT/AC.219/21.
West and Central Africa Regional Consultation on Global ‘Every Newborn’ Action Plan, July 2013 – Dakar, Senegal. Status of Newborn Health in the.
Headache, Blurred Vision, Convulsions, Loss of Consciousness or Elevated Blood Pressure Advances in Maternal and Neonatal Health.
 To educate pregnant women on the importance of prenatal care and educate them on the complications that pertain to human pregnancy.  To be knowledgeable.
Joy Riggs-Perla Imperial Royale Hotel, Kampala 26 June 2013 Session 3: Overview of the Every Newborn action plan.
Challenges of meeting MDG4 and MDG 5 in Bangladesh Prof. Kishwar Azad Project Director DAB-Perinatal Care Project.
B S M M U Scaling Up Interventions to Manage Birth Asphyxia in Bangladesh Prof. (Dr.) Mohammod Shahidullah Chairman, Dept. of Neonatology and Pro-Vice.
Comparing Globally Helps Locally Using International Comparisons for Advocacy and Education Rebecca Russell, MSPH Research Analyst March of Dimes, Perinatal.
JHPIEGO in partnership with Save the Children, Constella Futures, The Academy for Educational Development, The American College of Nurse-Midwives and IMA.
Preventing Maternal Deaths due to Pre-Eclampsia/Eclampsia (PE/E)
Max Brinsmead MB BS PhD May 2015 Maternal Mortality.
Child Health: How Have We Been Doing; Where to Now? An Update on MDG 4 and 5: Maternal and Child Health By Dr. Mickey Chopra, Chief, Health and Associate.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
South East Asia - Optimising Reproductive & Child Health Outcomes in Developing Countries SEA-ORCHID Project Centre for Perinatal Health Services Research,
SEVERE ACUTE MATERNAL MORBIDITY/NEAR MISS MATERNAL MORBIDITY Sangeetagupta Seniorconsultant&HOD, Deptt of Obst.&Gynae,ESIPGIMSR,Basaidarapur.
Arie Hoekman,UNFPA Representative Strengthening Midwifery to save lives and promote health of women and newborn 3rd MCH Annual Conference Nanchang, November.
Antenatal care MDG 5, Target 5b, Indicator 5.5
SOCIAL OBSTETRICS Defined as the study of the interplay of social and environmental factors and human reproduction going back to preconceptional.
Why Do Women Choose To Deliver At Home And Not In A Hospital? The Guatemala Case Study Fannie Fonseca-Becker, DrPH, MPH Irina Zablotska, MD, MPH, PhD candidate.
New Frontiers in Newborn Health: Stephen Wall, MD SM Senior Research Manager Saving Newborn Lives Save the Children.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
04_DirectorReport_PCC/1 9/2004 Rita Kabra_/1 Access to essential medicines for Maternal and Newborn Health Dr Rita Kabra Making Pregnancy Safer WHO/EDM.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Pre-Eclampsia/ Eclampsia Interventions and their Cost Effectiveness Interventions for Impact in Essential Obstetric and Newborn Care Africa Regional Meeting,
Africa Regional Meeting on Interventions for Impact in EmOC Feb 2011, Addis Ababa Maternal and Newborn Health in the African Region Africa Regional.
Scaling Up MA within the Context of SA Services in Nepal
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
Achieving Coverage and Compliance of Antenatal Calcium Supplementation for Prevention of Pre-eclampsia/Eclampsia– Findings from Nepal Dr Kusum Thapa FRCOG,
Reproductive Health class#2 Safe motherhood. Women’s Health Key facts.
International SBCC Summit
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Overview: Maternal and Child Health in Underdeveloped Countries (or: The World is NOT Flat) HServ/Epi 544 Winter Term 2007.
Global Evidence for the Use of Calcium for PE/E Prevention Jeffrey Michael Smith, MD, MPH Jhpiego / Johns Hopkins University Maternal Health Team Leader.
The evidence for going to scale with Calcium supplementation Harshad Sanghvi Vice-President & Medical Director, Jhpiego Senior Advisor, Accelovate/USAID,
Preventing Pre-Eclampsia: Supplementing Calcium In Nepal Harshad Sanghvi, Vice President Innovations & Medical Director, Jhpiego/Baltimore Kusum Thapa,
Antenatal care (ANC): Quality vs quantity – it’s the content that counts for improving pre-eclampsia /eclampsia (PEE) outcomes Sheena Currie, Senior Maternal.
Women’s Health Academic Centre CRADLE Community Blood Pressure Monitoring in Rural Africa: cfaDetection of Underlying Pre-eclampsia Hezelgrave N, Irvine.
MOHP Addresses Eclampsia, Leading Causes of Maternal Deaths in Nepal Dr. Shilu Aryal Sr. Consultant Obs/Gyn Family Health Division, Dept of Health Services,
Maternal Mortality Assistant Professor Dr. Batool A. Gh. Yassin Depart. Of Community & family Medicine Baghdad College of Medicine 2014.
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Quality Improvement An Introduction
HTN Complications of Pregnancy
Maternal Health Care Cont..
Introduction of maymay app
MOVING TO ACTION: Identifying Responses.
MATERNITY WARD NPH.
Antenatal care (ANC): Quality vs quantity – it’s the content that counts for improving pre-eclampsia /eclampsia (PEE) outcomes Sheena Currie, Senior.
But too many mothers and children die every year, Yes, more than half a million women die from pregnancy-related causes (that is 1 woman dying every minute).
Assessing and Monitoring Maternal Health Commodity Security
Presentation transcript:

Tackling the second biggest killer of mothers Harshad Sanghvi Vice President & Medical Director, Jhpiego Monday 10 March, 2010, Bangkok, Thailand

Why an additional Focus on PE/E  PE/E related mortality shows little decline in more than 75% of low resource countries  Disease targeted efforts within broad maternal and newborn care efforts are bearing fruit : eg Postabortion care, PPH, Infection prevention  Interventions are possible at all levels of health care system and high levels of coverage is feasible even outside formal healthcare systems Nepal Maternal Mortality Study 1998 & 2009 Cause of death PPH 37%19% Eclampsia14%21% Source: Nepal maternal mortality study preliminary findings

Strategies to consider including in country plans  Tertiary prevention:  Treatment of severe preeclampsia ( prevent eclampsia  Treatment of Eclampsia  Secondary Prevention: detecting Preeclampsia and timely delivery  Primary Prevention  Seeking simple, inexpensive and effective solutions that reach all pregnant women

Managing Preeclampsia  Monitoring for effects of PE on  Renal and other functions  Fetal growth and well being  Detecting severe Preeclampsia  Controlling high blood pressure  Preventing Seizures : Deciding when to institute Magnesium Sulphate therapy  On confirming diagnosis of Severe Preeclampsia  In the context of severe Preeclampsia once decision to deliver has been made  Timely Delivery / Care of term and preterm infants  Postpartum vigilance and care

Epsom Salts Gardens:  Help seeds germinate  Make plants grow bushier  Produce more flowers Spas: Dissolved in a bath, Epsom Salt  Ease stress  Create a happy, relaxed feeling  Raise energy levels On Mars:  The existence of Epsom salts on Mars was first suggested by the 1976 Viking mission and has since been confirmed by the Mars Exploration Rover as well as the Odyssey and Pathfinder missions

But sadly Epsom salt (Magnesium Sulphate) was not available for this woman who died of Eclampsia

Availability of magnesium sulfate & diazepam: Hospitals, health centers & posts in select countries

Preventing Eclampsia in women with Severe PE: Prophylactic magnesium sulphate  Halves risk of eclampsia  NNT 100, 95% CI 50 to 100  probably reduces maternal death  appears safe for baby  about a quarter of women have side effects, largely unpleasant rather than serious  applies to dosage in these trials, with clinical monitoring Lelia Duley et al

Results: Cost-effectiveness (95% CI) Courtesy: Lelia Duley

Treating Eclampsia Comparison between magnesium sulphate and diazepam: 5 trials 1236 women: comparison between magnesium sulphate and diazepam  More than 50% reduction in recurrence of convulsions RR % CI  For every 7 women treated with mgSo4 rather than diazepam, I case of recurrent convulsions prevented  Reduction in maternal mortality RR 0.60 ( )  Reduction in low apgar at 5 minutes RR 0.72 (95% CI ) Cochrane reviews

Choice of antihypertensive agents  Mild PE: up-to 109 Diastolic  24 trials, antihypertensives vs none RR of severe PE: 0.52 (95% CI: ) NNT is 9-17 to prevent 1 case of Severe PE  22 trials, comparison of drug No clear differences between metyldopa and labetolol, nifedipine Consider cost  Severe PE:diastolic over 110, proteinuria  No clear differences  Hydralazine may have advantages due to low cost, slightly better newborn outcomes Cochrane reviews

Understanding the Magnitude of the Challenge: Prevailing Practices Survey Prescribe progestagen agents for threatened abortion63% Use diazepam to control convulsions in eclampsia48% Never do ECV57% Do not use the partograph to monitor and manage labor88% Practice AMTS for “high risk” patients only42% Perform episiotomy in all primigravida32% Prescribe 5-7 days of antibiotics routinely for CS59 Perform Cesarean section mostly under general anesthesia 65% Do not wash hands before every vaginal exam in labor72% Sanghvi interviews with mid career faculty 16 countries, Asia, Africa, LAC

Using the SBMR Quality Improvement process to address systems challenges Guidelines Supervision Supplies Dangerous Practices Barriers to Access

Improving quality of Eclampsia Care: NESOG: professional associations playing a vital role  7 Govt SBA training sites (6 achieved 80%)  2 service sites (government hospitals)  6 private hospitals (1 achieved 80%)  4 medical colleges (3 achieved 80%)  3 PHCCs (1 achieved 80%) Results of a small grant from ACCESS/USAID

Treating Eclampsia: The Price of Delay  The sooner treatment starts, the better the survival rates  Treatment is relatively simple if instituted immediately  Magnesium sulphate and antihypertensive, delivery  Delayed treatment, especially beyond 2 hours, requires intensive care for shock, DIC, renal shutdown, respiratory failure, electrolyte disturbance, sepsis, pneumonia, and multi organ failure: Even in best centers, mortality is high Can we ensure immediacy of treatment where many births are occurring at home and where skilled care is not available?

Use of magnesium Sulphate and case fatality rate in eclampsia, Sadar hospital, Purulia, West Bengal, India, Trained46 MO, 55 Nursing Personnel

Experience With Single Dose of MgSO4 for Treatment of Eclampsia: DHAKA A randomized trial with 401 patients comparing efficacy of loading dose alone versus standard regime  Outcome:  Recurrent convulsion rate: 4.0% vs 3.5%.  Case fatality rate: 4.5% vs 5.0%.  Conclusion: For majority of patients a single loading dose alone will suffice  Implications: This simplified treatment makes it possible to treat eclampsia even at home Rashida Begum et al

Preventing Preeclampsia x x x x Almost 100 interventions tested in randomized trials Calcium 65% Reduction in pre-eclampsia RR 0.35, (95% CI 0.20 to 0.60). Aspirin 15% Reduction in Preeclampsia RR 0.85 (95% CI )

Effects of calcium supplementation during pregnancy in studies with low baseline calcium intake populations Relative Reduction (95%CI) 7 studies; women Hypertension Pre-eclampsia Maternal death or serious morbidity Perinatal death 14% (-6, 31) 53% (24, 71) 64% (30, 82) 20% (3, 35) Cochrane review

Daily calcium intake per capita in developing and developed countries (FAO, 1990) REGION CALCIUM (mg) World Developed countries Developing countries Africa Latin America Near East Far East Others

Mary Ellens’s Question: Iron distribution has largely failed so what makes you think that you can do better with calcium?  Of 60 major micronutrient supplementation programs (cost approx $1.3b) only 3 had a significant impact in reducing anemia in pregnancy. All three were CBD programs  Acceptability of Calcium tabs low : Women do not like swallowing large chalky tabs  Alternative calcium preps too expensive for large scale supplementation  Food-milk fortification not suitable in rural settings where most produce is home grown Sanghvi, 2008:PEE position paper Best question: How can we make calcium more affordable and acceptable

Planned solution  Sprinkles:  Calcium phosphate salt (powder) in Sachets  Calcium sprinkled on main meal  Tests on wide variety of Asian and African staple meals show very little taste or texture or smell effect  Will cost $0.92 for 100 sachets  Field trials, CBD, will start in Nepal 2010

Detecting Preeclampsia Measuring BP:  Significant training needed to do BP well  Robust and maintained equipment  Currently completely missing about 50% women who do not receive antenatal care,  Also missing an additional 15-30% who attend ANC but do not have BP taken Measuring urine protein  Urine dipstick tests quite pricey  Boiling not feasible in high volume sites

Preliminary Design Sanghvi, Crocker, Patent Pending Towards detecting all PE that exists in a community Sanghvi, Gauri, Shin, Patent Pending

Achieving Maximum Impact of reducing mortality from PE: From Household to Hospital Preventing PE: Qualitative study to develop suitable educational message, and identify best approach to distributing calcium Use existing Community health volunteer network for CBD of calcium Monitor coverage, acceptability, safety, impact and program effort/cost Detecting PE: Clinical detection of PE as standard AN service; monitor and supported at all levels Operations research in community detection of PE Strengthen referral centers Treating severe PE & Eclampsia: Review and disseminate protocol for Magnesium sulphate, antiHt Revise policy on who and where magnesium sulphate can be made available Ensure sufficient supplies and monitor Monitor use of protocols in facilities

All the interventions I have outlined today have been in the cart for 20 years

 Plan  Assess  Test  Validate  Manage  Implement  Monitor  Document  Scale up  Institutionalize  Objectives  Disease burden  Results  Resources  Impact  Coverage  Quality of care  Access  Effectiveness  Efficiency As public Health professionals we are taught to or focus on:

 Convince  Persuade  Negotiate  Recruit  Collaborate  Co-opt  Bypass  Overcome  Mobilize  Broker  Compromise  Advocacy  Partnership  Quid pro quo  Coalition  Opinion leader  Gate-keeper  Agendas  Motivation  Trust  Priority  Power But Bringing About Major changes requires us to Courtesy Steve Hodgins